Stocks
Adaptive Biotechnologies (ADPT) EBITDA margin US GAAP (year values) |
|||||||||
| 2020 | 2021 | 2022 | 2023 | 2023 | LTM ? | CAGR 5 years ? | |||
| EBITDA margin, % | ? | -146.7% | -125.3% | -90.7% | -105.3% | -111.2% | -92.2% | ||
| Changes by years, y/y, % | -64pp | +21pp | +35pp | -15pp | -6pp | +7.2% | |||
Adaptive Biotechnologies. EBITDA margin, %
Adaptive Biotechnologies. EBITDA margin, changes, pp
Adaptive Biotechnologies (ADPT) EBITDA margin US GAAP (quarter values) |
||||||||
| 2023Q4 | 2023Q4 | 2024Q1 | 2024Q2 | 2024Q3 | LTM ? | |||
| EBITDA margin, % | ? | -87.9% | -133.4% | -93.9% | -89.3% | -52.9% | -92.2% | |
| Changes by years, y/y, % | -22pp | -68pp | +36pp | -10pp | +50pp | |||
| Changes by quarters, q/q, % | +15pp | -45pp | +39pp | +5pp | +36pp | |||
